Oncology Central

Dual nanoparticle drug delivery: the future of anticancer therapies?


Current cancer therapies aim to reverse tumorigenesis through nonspecific elimination of cancer cells within the body, which can often result in systemic side effects for patients. Nanoparticles provide a unique platform for cancer therapeutics because their physical properties can be tailored to target-specific cancers, increase the bioavailability and accumulation of drugs, and reduce systemic effects of current therapies [1,2]. In recent years, nanoparticles for the treatment of cancer cells have evolved beyond a single delivery system to a realm of dual-loaded delivery of cancer therapeutics.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.





News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.